Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.74USD
4:00pm EDT
Change (% chg)

$0.12 (+7.41%)
Prev Close
$1.62
Open
$1.69
Day's High
$1.74
Day's Low
$1.60
Volume
25,494
Avg. Vol
3,801
52-wk High
$4.75
52-wk Low
$1.58

CBLI.OQ

Chart for CBLI.OQ

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company's programs are focused developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for CBLI.OQ.

Overall

Beta: 1.05
Market Cap(Mil.): $17.80
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 43.83 36.83
EPS (TTM): -0.67 -- --
ROI: -- -0.29 13.93
ROE: -- -2.99 14.84

BRIEF-Cleveland Biolabs quarterly loss per share $0.17

* Quarterly loss per share $0.17 Source text for Eikon: Further company coverage:

Aug 15 2016

BRIEF-Cleveland Biolabs posts a loss of $0.06 per share in Q1

* Cleveland Biolabs reports first quarter 2016 financial results and development progress

May 16 2016

BRIEF-Cleveland Biolabs and CFO Neil Lyons agreed on Lyon's termination of employment

* Co, Neil Lyons, Co's CFO mutually agreed that Lyons would terminate his employment with company effective May 6, 2016

May 06 2016

Earnings vs. Estimates